Alkermes appears to have successfully hit back with a counteroffer to buy sleep disorder drugmaker Avadel, following Lundbeck’s last-minute bid to acquire the latter. The latest offer saw Alkermes put ...
Alkermes is drafting a former Major League Baseball player who has struggled with his own alcohol addiction as spokesperson for its alcohol dependency awareness campaign. World Series winner and ...
Alkermes (NASDAQ:ALKS) is gearing up to announce its quarterly earnings on Thursday, 2024-10-24. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...
Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 44th Annual J.P. Morgan Healthcare Conference. The ...
The chair of an FDA panel believes the drug Dsuvia represents a “danger” to public health. Just two weeks after a rare rebuke from the Food and Drug Administration derailed Alkermes’s treatment for ...
On December 5, Piper Sandler analyst David Amsellem also reaffirmed his bullish view of Alkermes (NASDAQ:ALKS). He gave a Buy ...
(Reuters) - Drugmaker Alkermes said on Tuesday the U.S. Food and Drug Administration declined to approve its treatment for schizophrenia and bipolar disorder, citing concerns related to a tablet ...
– Alixorexton is the First Oral Orexin 2 Receptor Agonist to Demonstrate Efficacy in a Large Phase 2 Study in Patients With Narcolepsy Type 2, Supporting Advancement to Phase 3 – – Alixorexton Met the ...
Alkermes plans to spin out its oncology research division into a standalone entity, creating a potential value-unlocking transaction. The spin-off will allow Alkermes to focus on its neuroscience ...
DUBLIN, Sept. 11, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that it will begin accepting applications for its annual Alkermes Pathways Research Awards® program on Monday, Sept.
As biopharma grapples with a widespread gender diversity problem, Alkermes faces three lawsuits alleging discriminatory treatment toward female employees, with one suit even claiming it's the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback